| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.36 | 0.03 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.33 | 0.3 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.26 | 0.06 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.25 | 0.06 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | -0.19 | 0.2 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.16 | 0.3 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.16 | 0.0008 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.04 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.3 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.3 |